Showing results (3071-3080 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|April 10, 2013
Micro- and macrovascular treatment targets in scleroderma heart diseaseTheodoros Dimitroulas, George Giannakoulas, Haralambos Karvounis, et al.Current Pharmaceutical Design|April 10, 2013
MicroRNAs (miRNAs) in colorectal cancer: from aberrant expression towards therapyHannelore Dassow, Achim AignerCurrent Pharmaceutical Design|April 30, 2013
Mechanisms for targeted delivery of nanoparticles in cancerJaymes R Beech, Soo J Shin, Jeffrey A Smith, et al.Current Pharmaceutical Design|April 30, 2013
Nanomaterials for photohyperthermia: a reviewJonathan Fang, Yu-Chie ChenCurrent Pharmaceutical Design|March 30, 2013
Role of NUCB2/nesfatin-1 as a possible biomarkerSuleyman AydinCurrent Pharmaceutical Design|March 30, 2013
Role of NUCB2/nesfatin-1 in glucose control: diverse functions in islets, adipocytes and brainMasanori Nakata, Toshihiko YadaCurrent Pharmaceutical Design|March 30, 2013
Regulation of gastric nesfatin-1/NUCB2Ziru Li, Michael Mulholland, Weizhen ZhangCurrent Pharmaceutical Design|June 21, 2013
From gastroprotective to ulcerogenic effects of glucocorticoids: role of long-term glucocorticoid actionLudmila Filaretova, Tatiana Podvigina, Tatiana Bagaeva, et al.Current Pharmaceutical Design|June 25, 2013
Beyond the ITC White Paper: emerging sciences in drug transporters and opportunities for drug developmentYurong Lai, Peng HsiaoCurrent Pharmaceutical Design|June 25, 2013
Expression and function of organic cation and anion transporters (SLC22 family) in the CNSChristine A Farthing, Douglas H SweetPageof 1,008